No Insurance Required!
Click to Sign Up Today
Elixia Health is currently enrolling volunteers 18 to 65 years old for a clinical research study focused on anxiety. This study is evaluating an investigational medication that will be taken together with your current anxiety treatment to see if it may provide additional relief from symptoms. Participants will continue their regular prescribed medication and may receive study-related care at no cost.
Your privacy is important to us. By completing the following pre-screener you agree to our Privacy Policy and Terms of Use, and agree that we may retain the personal information you provide and share it with personnel involved in the study, or otherwise as described in the Privacy Policy, and we or our affiliates may contact you by phone using automated technology or pre-recorded voicemail or other means including but not limited to text messages (standard messaging rates may apply) regarding research studies.
Elixia Health is enrolling adults ages 18 to 65 who have been diagnosed with anxiety and are currently taking one of the following medications: Paxil (paroxetine), Lexapro (escitalopram), Cymbalta (duloxetine), or Effexor XR (venlafaxine ER).
This research study is evaluating how an investigational medication may work alongside these treatments to help improve symptoms and assess its safety for future use.
Why Anxiety Research Matters
Anxiety disorders are among the most common mental health conditions, affecting millions of people worldwide. Clinical research is essential for developing and improving therapies that can help people find better relief and increase quality of life.
By participating, you can contribute to scientific progress and help advance future treatments for anxiety.
Why Join a Clinical Research Study
t Elixia, we’re dedicated to advancing mental health research through clinical studies. Our goal is to help develop innovative anxiety treatments and support that may offer improvements over current options.
Your privacy is important to us. By completing the following pre-screener you agree to our Privacy Policy and Terms of Use, and agree that we may retain the personal information you provide and share it with personnel involved in the study, or otherwise as described in the Privacy Policy, and we or our affiliates may contact you by phone using automated technology or pre-recorded voicemail or other means including but not limited to text messages (standard messaging rates may apply) regarding research studies.